2023 TOS Summit (夏3冬_)
07/15 (Sat) ⬅️ (第一場 New drug, Pan-cancer, GU) 07/16 (Sun) ⬅️ (第二場 Breast, GI) 07/22 (Sat) ⬅️ (第三場 H&N, Solid tumor, Lung cancer)
2023 TOS Summit (夏3冬_) Read More »
07/15 (Sat) ⬅️ (第一場 New drug, Pan-cancer, GU) 07/16 (Sun) ⬅️ (第二場 Breast, GI) 07/22 (Sat) ⬅️ (第三場 H&N, Solid tumor, Lung cancer)
2023 TOS Summit (夏3冬_) Read More »
2022/07/10 (Sun) ⬅️ (第一場 Breast Cancer, Precision Medicine) 2022/07/16 (Sat) ⬅️ (第二場 GI) 2022/07/17 (Sun) ⬅️ (第三場 新藥、H&C、GU) 2022/07/24 (Sun) ⬅️ (第四場 肺癌 Lung Cancer) 2022/10/22 (Sat) ⬅️ (第一天 Updates on EMSO) 2022/10/23 (Sun) ⬅️ (第二天 Updates on EMSO)
2022 TOS Summit (夏4冬2) Read More »
Ginkgo Bioworks is an American biotech company founded in 2008 by five scientists from MIT, headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed “Organism Company” was one of the world’s largest privately held
Ginkgo Bioworks–這是什麼東東? Read More »